{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:24:27Z","timestamp":1790223867798,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA138313"],"award-info":[{"award-number":["CA138313"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA245143"],"award-info":[{"award-number":["CA245143"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA245143"],"award-info":[{"award-number":["CA245143"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA245143"],"award-info":[{"award-number":["CA245143"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA245143"],"award-info":[{"award-number":["CA245143"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Advanced glycation end products (AGEs) are reactive metabolites intrinsically linked with modern dietary patterns. Processed foods, and those high in sugar, protein and fat, often contain high levels of AGEs. Increased AGE levels are associated with increased breast cancer risk, however their significance has been largely overlooked due to a lack of direct cause-and-effect relationship.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To address this knowledge gap, FVB\/n mice were fed regular, low AGE, and high AGE diets from 3\u00a0weeks of age and mammary glands harvested during puberty (7\u00a0weeks) or adulthood (12\u00a0weeks and 7\u00a0months) to determine the effects upon mammary gland development. At endpoint mammary glands were harvested and assessed histologically (<jats:italic>n<\/jats:italic>\u2009\u2265\u20094). Immunohistochemistry and immunofluorescence were used to assess cellular proliferation and stromal fibroblast and macrophage recruitment. The Kruskal\u2013Wallis test were used to compare continuous outcomes among groups. Mammary epithelial cell migration and invasion in response to AGE-mediated fibroblast activation was determined in two-compartment co-culture models. In vitro experiments were performed in triplicate. The nonparametric Wilcoxon rank sum test was used to compare differences between groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Histological analysis revealed the high AGE diet delayed ductal elongation, increased primary branching, as well as increased terminal end bud number and size. The high AGE diet also led to increased recruitment and proliferation of stromal cells to abnormal structures that persisted into adulthood. Atypical hyperplasia was observed in the high AGE fed mice. Ex vivo fibroblasts from mice fed dietary-AGEs retain an activated phenotype and promoted epithelial migration and invasion of non-transformed immortalized and tumor-derived mammary epithelial cells. Mechanistically, we found that the receptor for AGE (RAGE) is required for AGE-mediated increases in epithelial cell migration and invasion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We observed a disruption in mammary gland development when mice were fed a diet high in AGEs. Further, both epithelial and stromal cell populations were impacted by the high AGE diet in the mammary gland. Educational, interventional, and pharmacological strategies to reduce AGEs associated with diet may be viewed as novel disease preventive and\/or therapeutic initiatives during puberty.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13058-023-01714-4","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T12:02:02Z","timestamp":1696593722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pubertal exposure to dietary advanced glycation end products disrupts ductal morphogenesis and induces atypical hyperplasia in the mammary gland"],"prefix":"10.1186","volume":"25","author":[{"given":"Bradley A.","family":"Krisanits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Randise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes M.","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson T.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowtami A.","family":"Panguluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Helke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Cuiti\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Koivisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Spruill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria J.","family":"Findlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"issue":"1","key":"1714_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1186\/s12889-019-7844-4","volume":"19","author":"G Sproesser","year":"2019","unstructured":"Sproesser G, Ruby MB, Arbit N, Akotia CS, Alvarenga MDS, Bhangaokar R, et al. Understanding traditional and modern eating: the TEP10 framework. BMC Public Health. 2019;19(1):1606.","journal-title":"BMC Public Health"},{"key":"1714_CR2","doi-asserted-by":"crossref","unstructured":"Rippe JM, Angelopoulos TJ. Relationship between added sugars consumption and chronic disease risk factors: current understanding. Nutrients. 2016;8(11).","DOI":"10.3390\/nu8110697"},{"issue":"3","key":"1714_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","volume":"28","author":"J Chaudhuri","year":"2018","unstructured":"Chaudhuri J, Bains Y, Guha S, Kahn A, Hall D, Bose N, et al. The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality. Cell Metab. 2018;28(3):337\u201352.","journal-title":"Cell Metab"},{"issue":"6","key":"1714_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jada.2010.03.018","volume":"110","author":"J Uribarri","year":"2010","unstructured":"Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911\u20136.","journal-title":"J Am Diet Assoc"},{"issue":"10","key":"1714_CR5","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1158\/0008-5472.CAN-15-0169","volume":"75","author":"DP Turner","year":"2015","unstructured":"Turner DP. Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity. Cancer Res. 2015;75(10):1925\u20139.","journal-title":"Cancer Res"},{"key":"1714_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2016.08.001","volume":"133","author":"DP Turner","year":"2017","unstructured":"Turner DP. The role of advanced glycation end-products in cancer disparity. Adv Cancer Res. 2017;133:1\u201322.","journal-title":"Adv Cancer Res"},{"key":"1714_CR7","doi-asserted-by":"crossref","unstructured":"Miranda ER, Fuller KNZ, Perkins RK, Beisswenger PJ, Farabi SS, Quinn L, et al. Divergent changes in plasma AGEs and sRAGE isoforms following an overnight fast in T1DM. Nutrients. 2019;11(2).","DOI":"10.3390\/nu11020386"},{"issue":"6","key":"1714_CR8","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1021\/acs.jafc.7b05955","volume":"66","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Snooks H, Sang S. Complexity of advanced glycation end products in foods: where are we now? J Agric Food Chem. 2018;66(6):1325\u20139.","journal-title":"J Agric Food Chem"},{"key":"1714_CR9","unstructured":"Liang Z, Chen X, Li L, Li B, Yang Z. The fate of dietary advanced glycation end products in the body: from oral intake to excretion. Crit Rev Food Sci Nutrit. 2019:1\u201317."},{"issue":"21","key":"1714_CR10","doi-asserted-by":"publisher","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","volume":"267","author":"M Neeper","year":"1992","unstructured":"Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem. 1992;267(21):14998\u20135004.","journal-title":"J Biol Chem"},{"key":"1714_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fgene.2017.00187","volume":"8","author":"LM Senatus","year":"2017","unstructured":"Senatus LM, Schmidt AM. The AGE-RAGE axis: implications for age-associated arterial diseases. Front Genet. 2017;8:187.","journal-title":"Front Genet"},{"issue":"20","key":"1714_CR12","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1021\/bi500046t","volume":"53","author":"J Xue","year":"2014","unstructured":"Xue J, Ray R, Singer D, Bohme D, Burz DS, Rai V, et al. The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs. Biochemistry. 2014;53(20):3327\u201335.","journal-title":"Biochemistry"},{"key":"1714_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1196\/annals.1333.052","volume":"1043","author":"J Uribarri","year":"2005","unstructured":"Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contributors to the body\u2019s AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci. 2005;1043:461\u20136.","journal-title":"Ann N Y Acad Sci"},{"key":"1714_CR14","doi-asserted-by":"crossref","unstructured":"Omofuma O TD, Peterson LL, Merchant A, Zhang J, Steck S. Dietary advanced glycation end-products (AGEs) and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO). Cancer Prevent Res. 2020;In press.","DOI":"10.1158\/1940-6207.CAPR-19-0457"},{"key":"1714_CR15","doi-asserted-by":"crossref","unstructured":"Peterson LL PY, Colditz GA, Anbardar N, Turner DP. Dietary advanced glycation end products and risk of postmenopausal breast cancer in the NIH-AARP diet and health study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2020;In press.","DOI":"10.1158\/1538-7445.SABCS18-619"},{"issue":"12","key":"1714_CR16","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1158\/1055-9965.EPI-21-0610","volume":"30","author":"OO Omofuma","year":"2021","unstructured":"Omofuma OO, Peterson LL, Turner DP, Merchant AT, Zhang J, Thomson CA, et al. Dietary advanced glycation end-products and mortality after breast cancer in the women\u2019s health initiative. Cancer Epidemiol Biomarkers Prev. 2021;30(12):2217\u201326.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1714_CR17","doi-asserted-by":"crossref","unstructured":"Bradley Krisanits JFR, Clare E. Burton, Victoria J. Findlay and David P. Turner. Pubertal mammary development as a \u2018susceptibility window\u2019 for breast cancer disparity. Adv Can Res. 2020;In Press.","DOI":"10.1016\/bs.acr.2020.01.004"},{"issue":"5","key":"1714_CR18","first-page":"567","volume":"4","author":"GA Colditz","year":"1995","unstructured":"Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomark Prevent. 1995;4(5):567\u201371.","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"10","key":"1714_CR19","doi-asserted-by":"publisher","first-page":"2697S","DOI":"10.1093\/jn\/136.10.2697S","volume":"136","author":"L Hilakivi-Clarke","year":"2006","unstructured":"Hilakivi-Clarke L, Shajahan A, Yu B, de Assis S. Differentiation of mammary gland as a mechanism to reduce breast cancer risk. J Nutrit. 2006;136(10):2697S-S2699.","journal-title":"J Nutrit"},{"issue":"5920","key":"1714_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/303767a0","volume":"303","author":"MC Pike","year":"1983","unstructured":"Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. \u201cHormonal\u201d risk factors, \u201cbreast tissue age\u201d and the age-incidence of breast cancer. Nature. 1983;303(5920):767\u201370.","journal-title":"Nature"},{"issue":"2","key":"1714_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10911-009-9123-y","volume":"14","author":"DC Radisky","year":"2009","unstructured":"Radisky DC, Hartmann LC. Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia. 2009;14(2):181\u201391.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"4","key":"1714_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/wdev.35","volume":"1","author":"H Macias","year":"2012","unstructured":"Macias H, Hinck L. Mammary gland development. Wiley Interdiscip Rev Dev Biol. 2012;1(4):533\u201357.","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"2","key":"1714_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10911-017-9372-0","volume":"22","author":"IS Paine","year":"2017","unstructured":"Paine IS, Lewis MT. The Terminal End Bud: the Little Engine that Could. J Mammary Gland Biol Neoplasia. 2017;22(2):93\u2013108.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"1714_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/1477-3163.119606","volume":"12","author":"S Sundaram","year":"2013","unstructured":"Sundaram S, Johnson AR, Makowski L. Obesity, metabolism and the microenvironment: links to cancer. J Carcinog. 2013;12:19.","journal-title":"J Carcinog"},{"issue":"11","key":"1714_CR25","first-page":"2537","volume":"7","author":"KS Veena","year":"2013","unstructured":"Veena KS, Subitha L, VR HK, Bupathy A. Menstrual abnormalities in school going girls\u2013are they related to dietary and exercise pattern? J Clin Diagnost Res JCDR. 2013;7(11):2537.","journal-title":"J Clin Diagnost Res JCDR"},{"key":"1714_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev-publhealth-031914-122606","volume":"37","author":"E Villamor","year":"2016","unstructured":"Villamor E, Jansen EC. Nutritional determinants of the timing of puberty. Annu Rev Public Health. 2016;37:33\u201346.","journal-title":"Annu Rev Public Health"},{"key":"1714_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101350","volume":"17","author":"BA Krisanits","year":"2022","unstructured":"Krisanits BA, Woods P, Nogueira LM, Woolfork DD, Lloyd CE, Baldwin A, et al. Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts. Transl Oncol. 2022;17: 101350.","journal-title":"Transl Oncol"},{"issue":"11","key":"1714_CR28","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1172\/JCI200418704","volume":"113","author":"B Liliensiek","year":"2004","unstructured":"Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, Hofer S, et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004;113(11):1641\u201350.","journal-title":"J Clin Invest"},{"issue":"4","key":"1714_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035143","volume":"7","author":"R Patel","year":"2012","unstructured":"Patel R, Baker SS, Liu W, Desai S, Alkhouri R, Kozielski R, et al. Effect of dietary advanced glycation end products on mouse liver. PLoS ONE. 2012;7(4): e35143.","journal-title":"PLoS ONE"},{"issue":"3","key":"1714_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/0192623308315665","volume":"36","author":"FR Westwood","year":"2008","unstructured":"Westwood FR. The female rat reproductive cycle: a practical histological guide to staging. Toxicol Pathol. 2008;36(3):375\u201384.","journal-title":"Toxicol Pathol"},{"issue":"4","key":"1714_CR31","doi-asserted-by":"publisher","first-page":"R70","DOI":"10.1186\/bcr3464","volume":"15","author":"QJ Guo","year":"2013","unstructured":"Guo QJ, Mills JN, Bandurraga SG, Nogueira LM, Mason NJ, Camp ER, et al. MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer. Breast Cancer Res. 2013;15(4):R70.","journal-title":"Breast Cancer Res"},{"issue":"7","key":"1714_CR32","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1242\/dev.108258","volume":"141","author":"E Villegas","year":"2014","unstructured":"Villegas E, Kabotyanski EB, Shore AN, Creighton CJ, Westbrook TF, Rosen JM. Plk2 regulates mitotic spindle orientation and mammary gland development. Development. 2014;141(7):1562\u201371.","journal-title":"Development"},{"issue":"7","key":"1714_CR33","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1002\/j.1460-2075.1988.tb03048.x","volume":"7","author":"RK Ball","year":"1988","unstructured":"Ball RK, Friis RR, Schoenenberger CA, Doppler W, Groner B. Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 1988;7(7):2089\u201395.","journal-title":"EMBO J"},{"issue":"1","key":"1714_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10585-005-2908-5","volume":"22","author":"AD Borowsky","year":"2005","unstructured":"Borowsky AD, Namba R, Young LJ, Hunter KW, Hodgson JG, Tepper CG, et al. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis. 2005;22(1):47\u201359.","journal-title":"Clin Exp Metastasis"},{"issue":"11","key":"1714_CR35","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.2337\/diabetes.52.11.2805","volume":"52","author":"M Peppa","year":"2003","unstructured":"Peppa M, Brem H, Ehrlich P, Zhang JG, Cai W, Li Z, et al. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes. 2003;52(11):2805\u201313.","journal-title":"Diabetes"},{"issue":"6","key":"1714_CR36","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2337\/diabetes.52.6.1441","volume":"52","author":"M Peppa","year":"2003","unstructured":"Peppa M, He C, Hattori M, McEvoy R, Zheng F, Vlassara H. Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. Diabetes. 2003;52(6):1441\u20138.","journal-title":"Diabetes"},{"issue":"3","key":"1714_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10549-018-4992-7","volume":"173","author":"KR Walter","year":"2019","unstructured":"Walter KR, Ford ME, Gregoski MJ, Kramer RM, Knight KD, Spruill L, et al. Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019;173(3):559\u201371.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1714_CR38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1023\/A:1026499523505","volume":"5","author":"MM Richert","year":"2000","unstructured":"Richert MM, Schwertfeger KL, Ryder JW, Anderson SM. An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia. 2000;5(2):227\u201341.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"24","key":"1714_CR39","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1007\/s00018-007-7386-2","volume":"64","author":"F Lanigan","year":"2007","unstructured":"Lanigan F, O\u2019Connor D, Martin F, Gallagher WM. Molecular links between mammary gland development and breast cancer. Cell Mol Life Sci CMLS. 2007;64(24):3159\u201384.","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"7527","key":"1714_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature13992","volume":"515","author":"F Yue","year":"2014","unstructured":"Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T, et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature. 2014;515(7527):355\u201364.","journal-title":"Nature"},{"issue":"1","key":"1714_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (New York, NY). 2004;6(1):1\u20136.","journal-title":"Neoplasia (New York, NY)"},{"issue":"5","key":"1714_CR42","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nm1764","volume":"14","author":"G Finak","year":"2008","unstructured":"Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med. 2008;14(5):518\u201327.","journal-title":"Nat Med"},{"issue":"1","key":"1714_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s10020-018-0060-3","volume":"24","author":"SL Fishman","year":"2018","unstructured":"Fishman SL, Sonmez H, Basman C, Singh V, Poretsky L. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Mol Med. 2018;24(1):59.","journal-title":"Mol Med"},{"issue":"1","key":"1714_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40364-020-00245-w","volume":"8","author":"C Han","year":"2020","unstructured":"Han C, Liu T, Yin R. Biomarkers for cancer-associated fibroblasts. Biomark Res. 2020;8(1):64.","journal-title":"Biomark Res"},{"key":"1714_CR45","unstructured":"Health and Behavior: The Interplay of Biological, Behavioral, and Societal Influences. The National Academies Collection: Reports funded by National Institutes of Health. Washington (DC)2001."},{"issue":"4S","key":"1714_CR46","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/j.jadohealth.2016.06.021","volume":"59","author":"JK Das","year":"2016","unstructured":"Das JK, Salam RA, Arshad A, Finkelstein Y, Bhutta ZA. Interventions for adolescent substance abuse: an overview of systematic reviews. J Adolesc Health. 2016;59(4S):S61\u201375.","journal-title":"J Adolesc Health"},{"issue":"3","key":"1714_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/PI.S12431","volume":"2011","author":"S Kelly-Weeder","year":"2011","unstructured":"Kelly-Weeder S, Phillips K, Rounseville S. Effectiveness of public health programs for decreasing alcohol consumption. Patient Intell. 2011;2011(3):29\u201338.","journal-title":"Patient Intell"},{"issue":"7","key":"1714_CR48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1158\/1940-6207.CAPR-19-0457","volume":"13","author":"OO Omofuma","year":"2020","unstructured":"Omofuma OO, Turner DP, Peterson LL, Merchant AT, Zhang J, Steck SE. Dietary advanced glycation end-products (AGE) and risk of breast cancer in the prostate, lung, colorectal and ovarian cancer screening trial (PLCO). Cancer Prev Res (Phila). 2020;13(7):601\u201310.","journal-title":"Cancer Prev Res (Phila)"},{"key":"1714_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2014.02.006","volume":"25","author":"J Paulsson","year":"2014","unstructured":"Paulsson J, Micke P. Prognostic relevance of cancer-associated fibroblasts in human cancer. Semin Cancer Biol. 2014;25:61\u20138.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1714_CR50","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13058-015-0646-4","volume":"17","author":"MD Aupperlee","year":"2015","unstructured":"Aupperlee MD, Zhao Y, Tan YS, Zhu Y, Langohr IM, Kirk EL, et al. Puberty-specific promotion of mammary tumorigenesis by a high animal fat diet. Breast Cancer Res. 2015;17(1):138.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1714_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJMsr1407164","volume":"372","author":"LC Hartmann","year":"2015","unstructured":"Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast\u2013risk assessment and management options. New Engl J Med. 2015;372(1):78\u201389.","journal-title":"New Engl J Med"},{"issue":"11","key":"1714_CR52","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1002\/cncr.32798","volume":"126","author":"LL Peterson","year":"2020","unstructured":"Peterson LL, Park S, Park Y, Colditz GA, Anbardar N, Turner DP. Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study. Cancer. 2020;126(11):2648\u201357.","journal-title":"Cancer"},{"issue":"15","key":"1714_CR53","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.2174\/092986707780830989","volume":"14","author":"SJ Cho","year":"2007","unstructured":"Cho SJ, Roman G, Yeboah F, Konishi Y. The road to advanced glycation end products: a mechanistic perspective. Curr Med Chem. 2007;14(15):1653\u201371.","journal-title":"Curr Med Chem"},{"issue":"12","key":"1714_CR54","doi-asserted-by":"publisher","first-page":"7561","DOI":"10.1007\/s13197-015-1851-y","volume":"52","author":"C Sharma","year":"2015","unstructured":"Sharma C, Kaur A, Thind SS, Singh B, Raina S. Advanced glycation End-products (AGEs): an emerging concern for processed food industries. J Food Sci Technol. 2015;52(12):7561\u201376.","journal-title":"J Food Sci Technol"},{"issue":"5","key":"1714_CR55","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1111\/1541-4337.12593","volume":"19","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Wang Y, Fu L. Dietary advanced glycation end-products: perspectives linking food processing with health implications. Compr Rev Food Sci Food Saf. 2020;19(5):2559\u201387.","journal-title":"Compr Rev Food Sci Food Saf"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-023-01714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-023-01714-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-023-01714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T06:21:30Z","timestamp":1730269290000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-023-01714-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,6]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1714"],"URL":"https:\/\/doi.org\/10.1186\/s13058-023-01714-4","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,6]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal care and procedures were approved by the Institutional Animal Care and Use Committee at the Medical University of South Carolina, Approval # ARC-2995 and ARC-3167.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"VJF and DPT declare a non-financial competing interest as co-founders and board members of the Anti-AGEs Foundation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}